BEIJING (CAIXIN GLOBAL) - As the fast-evolving coronavirus tests scientists' capacity to develop more-effective vaccines, drugmakers in China are scrambling to catch up with the most advanced technology for producing more powerful shots to better protect the world's largest population.
Since the pandemic started, China has approved seven home-grown Covid-19 vaccines using four proven technologies to back the country's vaccination campaign, the world's largest. But shots based on the new mRNA technology that have been widely used elsewhere are still not available in China. MRNA vaccines, led by products developed by Pfizer-BioNTech and Moderna, have outperformed most other shots in efficacy rates against Covid-19.
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you
